{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:04:31Z","timestamp":1774494271411,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T00:00:00Z","timestamp":1716681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T00:00:00Z","timestamp":1716681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s12185-024-03774-4","type":"journal-article","created":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T14:01:32Z","timestamp":1716732092000},"page":"252-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["B-cell prolymphocytic leukemia: an enduring bona fide entity"],"prefix":"10.1007","volume":"120","author":[{"given":"Miguel S.","family":"Gonzalez-Mancera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Lopategui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumire","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serhan","family":"Alkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,26]]},"reference":[{"key":"3774_CR1","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IB de O, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. Springer US; 2022."},{"key":"3774_CR2","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee. Blood. 2022."},{"key":"3774_CR3","unstructured":"Swerdlow S, Campo E, Harris N, Al E. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4t. Lyon, France: IARC; 2017."},{"key":"3774_CR4","doi-asserted-by":"crossref","unstructured":"Melo J V., Catovsky D, Galton DAG. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia: II. patterns of evolution of \u2018prolymphocytoid\u2019 transformation. Br J Haematol. 1986;64:77\u201386.","DOI":"10.1111\/j.1365-2141.1986.tb07575.x"},{"key":"3774_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/10428199809057600","volume":"31","author":"G Cartron","year":"1998","unstructured":"Cartron G, Linassier C, Bremond JL, Desablens B, Georget MT, Fimbel B, et al. CD5 negative B-cell chronic lymphocytic leukemia: clinical and biological features of 42 cases. Leuk Lymphoma. 1998;31:209\u201316.","journal-title":"Leuk Lymphoma"},{"key":"3774_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1309\/PPK0-TJUK-1UAR-3194","volume":"115","author":"E Schlette","year":"2001","unstructured":"Schlette E, Bueso-Ramos C, Giles F, Glassman A, Hayes K, Medeiros LJ. Mature B-cell leukemias with more than 55% prolymphocytes: a heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol. 2001;115:571\u201381.","journal-title":"Am J Clin Pathol"},{"key":"3774_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/jclinpath-2015-202862","volume":"68","author":"T Menter","year":"2015","unstructured":"Menter T, Dirnhofer S, Tzankov A. LEF1: A highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia\/small lymphocytic B cell lymphoma. J Clin Pathol. 2015;68:473\u20138.","journal-title":"J Clin Pathol"},{"key":"3774_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/ijlh.12857","volume":"40","author":"YS Ting","year":"2018","unstructured":"Ting YS, Smith SABC, Brown DA, Dodds AJ, Fay KC, Ma DDF, et al. CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry. Int J Lab Hematol. 2018;40:533\u20139.","journal-title":"Int J Lab Hematol"},{"key":"3774_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1309\/AJCPUBHM8U7ZFLOB","volume":"142","author":"E Flatley","year":"2014","unstructured":"Flatley E, Chen AI, Zhao X, Jaffe ES, Dunlap JB, Pittaluga S, et al. Aberrations of MYC are a common event in B-cell prolymphocytic leukemia. Am J Clin Pathol. 2014;142:347\u201354.","journal-title":"Am J Clin Pathol"},{"key":"3774_CR10","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood-2019-121480","volume":"134","author":"E Chapiro","year":"2019","unstructured":"Chapiro E, Pramil E, Diop M, Roos-Weil D, Dillard C, Gabillaud C, et al. Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53. Blood. 2019;134:1821\u201331.","journal-title":"Blood"},{"key":"3774_CR11","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1038\/leu.2009.137","volume":"23","author":"I Del Giudice","year":"2009","unstructured":"Del Giudice I, Osuji N, Dexter T, Brito-Babapulle V, Parry-Jones N, Chiaretti S, et al. B-cell prolymphocytic leukemia and chronic lymphocytic leukemia have distinctive gene expression signatures. Leukemia. 2009;23:2160\u20137.","journal-title":"Leukemia"},{"key":"3774_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00277-011-1393-y","volume":"91","author":"N Put","year":"2012","unstructured":"Put N, Van Roosbroeck K, Konings P, Meeus P, Brusselmans C, Rack K, et al. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course. Ann Hematol. 2012;91:863\u201373.","journal-title":"Ann Hematol"},{"key":"3774_CR13","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","volume":"116","author":"M Salido","year":"2010","unstructured":"Salido M, Bar\u00f3 C, Oscier D, Stamatopoulos K, Dierlamm J, Matutes E, et al. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group. Blood. 2010;116:1479\u201388.","journal-title":"Blood"},{"key":"3774_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/PAS.0000000000000758","volume":"41","author":"Z Hu","year":"2017","unstructured":"Hu Z, Medeiros LJ, Chen Z, Chen W, Li S, Konoplev SN, et al. Mantle cell lymphoma with MYC rearrangement: a report of 17 patients. Am J Surg Pathol. 2017;41:216\u201324.","journal-title":"Am J Surg Pathol"},{"key":"3774_CR15","unstructured":"NCCN Guidelines Version 2.2023 Chronic Lymphocytic Leukemia\/Small Lymphocytic Lymphoma."},{"key":"3774_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3109\/10428199909093739","volume":"33","author":"L Shvidel","year":"1999","unstructured":"Shvidel L, Shtalrid M, Bassous L, Klepfish A, Vorst E, Berrebiz A. B-Cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course. Leuk Lymphoma. 1999;33:169\u201379.","journal-title":"Leuk Lymphoma"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03774-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03774-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03774-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T07:02:23Z","timestamp":1722150143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03774-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,26]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["3774"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03774-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,26]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}